[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351325-105":59,"doc-detail-351325-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-association-between-preexisting-cardiovascular-disease-and-cancer-treatment-receipt-in-a-population-based-cancer-registry","The association between preexisting cardiovascular disease and cancer treatment receipt in a population-based cancer registry","","Baseline cardiovascular disease is linked with poorer cancer outcomes, yet the mechanisms remain unclear, potentially involving reduced treatment receipt. This study estimated associations between pre-existing CVD and cancer treatment uptake using population-based cancer registry records from adults diagnosed with cancer in Northern Ireland from 2009–2019, linked to comorbidity and treatment data. Multivariable logistic regression and time-to-treatment analyses assessed odds of receiving chemotherapy, radiotherapy, surgery, and hormone therapy across tumor and CVD subgroup combinations.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-association-between-preexisting-cardiovascular-disease-and-cancer-treatment-receipt-in-a-population-based-cancer-registry/351325/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-association-between-preexisting-cardiovascular-disease-and-cancer-treatment-receipt-in-a-population-based-cancer-registry/351325.png","ImageObject",300,407,{"name":92,"@type":93},"Connor ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the study investigating about patients with pre-existing cardiovascular disease?","Question",{"text":113,"@type":114},"It examines how pre-existing CVD is associated with whether cancer patients receive different cancer treatments, using population-based registry data.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were treatment associations estimated in the study?",{"text":118,"@type":114},"Adjusted odds ratios were calculated using multivariable logistic regression, with subgroup analyses across tumor sites, cardiovascular conditions, and treatment modalities.",{"name":120,"@type":111,"acceptedAnswer":121},"What factors were used to analyze time to treatment?",{"text":122,"@type":114},"Kaplan-Meier curves and Cox proportional hazards models were used to analyze time to treatment after diagnosis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},351325,1790912554,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687207022233,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nThe association between preexisting cardiovascular disease and cancer treatment receipt in a population-based cancer registry  \nHüseyin Küçükali1,2,3􀀍, Gerard M. Walls4,5, Damien Bennett1,2,6, Anna Gavin1,2,6, Mark Harbinson2 & Ciaran O’Neill1,2  \nBaseline cardiovascular disease (CVD) has been linked with poorer outcomes for patients with cancer. The precise mechanisms underpinning that are poorly understood but may include reduced treatment receipt. We estimated the association between pre-existing CVD and cancer treatment receipt using population-based cancer registry records. Records of all adults diagnosed with cancer (excluding non-melanoma skin cancer) in Northern Ireland in 2009–2019 were linked with comorbidity and treatment data. The adjusted odds ratios (aOR) of receiving various cancer treatments for patients with previous cardiovascular diagnoses were estimated using multivariable logistic regression, adjusting for established confounders. Subgroup analyses were conducted for combinations of 24 tumour sites, 11 cardiovascular conditions, and 5 cancer treatment modalities. Kaplan-Meier curvesand Cox proportional hazards model were used to analyse time to treatment. 81,341 cancer patients were included, with a mean age of 67.1 ± 14.1 years. The most common cancers included were breast (15.8%), lung (14.1%) and colorectal cancer (13.5%). Patients with pre-existing CVD (23.4%) were 30% less likely to receive any cancer treatment than patients without (aOR = 0.70 [95%CI 0.67, 0.73]) . This reduction varied between treatment modalities with 30% for chemotherapy (aOR = 0.70 [95%CI  \n0.67, 0.73]), 28% for radiotherapy (aOR = 0.72 [95%CI 0.66, 0.79]), and 23% for surgery (aOR = 0.77 [95%CI 0.74, 0.80]). Hormone therapy showed no significant overall difference (aOR = 1.02 [95%CI 0.94, 1.11]). At 6 months post-diagnosis, patients with pre-existing CVD had a 14%(0.14 [95%CI 0.13, 0.15]) lower probability of initiating cancer treatment compared to those without. Pre-existing CVD was associated with an overall lower odds of cancer treatment, although the magnitude of this decrement varied according to the primary tumour, treatment modality and the type of CVD. These data present granular population-based insights into the impact of cardiovascular comorbidities on receiving cancer treatment and should be accounted for when reporting survival variations and healthcare policymaking.  \nKeywords Cardio-oncology, Cardiotoxicity, Comorbidity, Multimorbidity, Cancer registration  \nBackground  \nWhile cardio-oncology remains a relatively new sub-speciality, its growth and evolution have been rapid1. Reasons postulated for this expansion include the ageing population, enhanced cancer survivorship focus, anda greater appreciation of the impact of some cancer therapies on cardiovascular risks2,3. Early contributions to this literature have been dedicated to scoping the landscape of this interdisciplinary field for key gaps in clinical  \n1Centre for Public Health, Queen’s University Belfast, Grosvenor Road, Belfast BT12 6BA, UK. 2School of Medicine Dentistry and Biomedical Sciences, Queen’s University Belfast, Grosvenor Road, Belfast BT12 6BA, UK. 3Research Center for Healthcare Systems and Policies, Istanbul Medipol University, Istanbul, Türkiye. 4Cancer Centre Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, UK. 5Johnston Cancer Research Centre, Queen’s University Belfast, Belfast, UK. 6Northern Ireland Cancer Registry, Queen’s University Belfast, Belfast, UK. 􀀍 email: [h.kucukali@qub.ac.uk](h.kucukali@qub.ac.uk)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \npractice. These gaps include the importance of predicting outcomes4 for cancer patients with pre-existing cardiovascular disease, in order to guide cardiac optimisation and monitoring. Equally, the resource implication of concomitant cardiovascular disease ","cbCaimXp3Pp9CtHP","https://ap.wps.com/l/cbCaimXp3Pp9CtHP","pdf",2610346,"English","# Background\n## Study rationale for cardio-oncology\n## Need for real-world evidence in other populations\n# Methods\n## Study setting and data","[{\"question\":\"What is the study investigating about patients with pre-existing cardiovascular disease?\",\"answer\":\"It examines how pre-existing CVD is associated with whether cancer patients receive different cancer treatments, using population-based registry data.\"},{\"question\":\"How were treatment associations estimated in the study?\",\"answer\":\"Adjusted odds ratios were calculated using multivariable logistic regression, with subgroup analyses across tumor sites, cardiovascular conditions, and treatment modalities.\"},{\"question\":\"What factors were used to analyze time to treatment?\",\"answer\":\"Kaplan-Meier curves and Cox proportional hazards models were used to analyze time to treatment after diagnosis.\"}]","The association between preexisting cardiovascular disease and cancer treatment receipt in a population-based cancer registry | PDF",1790093566,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ef476c7b61f3faf1bf438f25fcd9676.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a4480e3ab9700eff4b518e9a3cd2246.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/107c89d719ce8b859313f94944857c82.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e93c79a5cb55c7f0d80431c41841ddae.webp",980,1287]